Prevalence and Impact of Cirrhotic Cardiomyopathy on Adverse Outcomes Following Liver Transplantation: A Systematic Review and a Meta-Analysis
{{output}}
Background: Approximately 30-50% of liver transplant patients have underlying cirrhotic cardiomyopathy (CCM), which may contribute to post-transplant complications such as mortality and heart failure (HF). However, the results ar... ...
